ClinicalTrials.gg
Sign In

Hypovolemia clinical trials

The registry lists 122 studies for Hypovolemia across more than 10 countries. 14 are recruiting or about to start. 70 of them are mainly about Hypovolemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Hypovolemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
78
Status unknown
17
Recruiting
9
Terminated
6
Not yet recruiting
5
Active, not recruiting
3

Phase

Phase 4
15
Phase 3
9
Phase 2
4
Phase 1
1
Early Phase 1
1

Where

France
18
United States
17
Italy
9
Sweden
8
Korea, Republic of
8
Denmark
6

Who runs them

Seoul National University Hospital (6) · Oslo University Hospital (5) · University Hospital, Caen (3) · Rigshospitalet, Denmark (3) · Karolinska Institutet (3) · University Hospital, Clermont-Ferrand (3) · Ottawa Hospital Research Institute (2) · Assiut University (2)

What is being tested here

Drugs under test in Hypovolemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Centhaquine101
Norepinephrine111
Albumins003
Sodium Chloride002
Sodium Acetate001
Potassium Chloride001
Calcium Chloride001
Magnesium Chloride001
Ringer's Lactate001
Saline Solution001

Coming up

1phase 3 study under way
10studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 9 Hypovolemia studies recruiting now, 5 (56%) set no upper age limit and 4 (44%) stop at 75 or younger. 2 (22%) take children under 18. 1 (11%) are for women only and 0 (0%) for men only; 1 (11%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
101 (11%)1 (11%)
187 (78%)6 (67%)
308 (89%)7 (78%)
408 (89%)7 (78%)
507 (78%)6 (67%)
656 (67%)6 (67%)
755 (56%)5 (56%)
855 (56%)5 (56%)

Across all 122 studies, recruiting or not: 33% stop at 75 or younger and 27% at 65; 15% take children; 2% are for women only and 2% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hypovolemia studies take

Of 25 observational studies under Hypovolemia, half reached primary completion within 15 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase12 mo8–20 · 19 studies——
Observational15 mo10–30 · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Studies

Recruiting first, then most recently updated. Showing 50 of 122. Browse all 122 → or search them.